These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19223877)

  • 1. Adding a medicine to the WHO model list of essential medicines.
    Kishore SP; Herbstman BJ
    Clin Pharmacol Ther; 2009 Mar; 85(3):237-9. PubMed ID: 19223877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. World Health Organization and Essential Medicines.
    Dugani S; Wasan KM; Kissoon N
    J Pharm Sci; 2018 May; 107(5):1261-1262. PubMed ID: 29277641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.
    Kishore SP; Blank E; Heller DJ; Patel A; Peters A; Price M; Vidula M; Fuster V; Onuma O; Huffman MD; Vedanthan R
    J Am Coll Cardiol; 2018 Feb; 71(5):564-574. PubMed ID: 29406862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On Essentiality and the World Health Organization's Model List of Essential Medicines.
    Marks VA; Latham SR; Kishore SP
    Ann Glob Health; 2017; 83(3-4):637-640. PubMed ID: 29221540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How should we balance individual and population benefits of statins for preventing cardiovascular disease?
    Hingorani AD; Hemingway H
    BMJ; 2010 Jan; 342():c6244. PubMed ID: 21270079
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region.
    Mehrtash H; Laing R; Wirtz VJ
    East Mediterr Health J; 2018 Jul; 24(5):427-434. PubMed ID: 30043961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).
    World Health Organ Tech Rep Ser; 2006; (933):1-119, back cover. PubMed ID: 17566509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries.
    Bazargani YT; Ugurlu M; de Boer A; Leufkens HGM; Mantel-Teeuwisse AK
    BMC Cardiovasc Disord; 2018 Jun; 18(1):126. PubMed ID: 29940880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between essential medicines and health outcomes for cardiovascular disease.
    Steiner L; Fraser S; Maraj D; Persaud N
    BMC Cardiovasc Disord; 2021 Mar; 21(1):151. PubMed ID: 33765933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [100 essential drugs. An internal medicine approach].
    Thomas M; Arlet P; Aumaitre O; Cosserat J; Grosbois B; Guillevin L; Kettaneh A; Le Jeunne C; Massot C; Morlat P
    Rev Med Interne; 2013 Aug; 34(8):460-4. PubMed ID: 23643757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Health Organization essential medicines lists: where are the drugs to treat neuropathic pain?
    Kamerman PR; Wadley AL; Davis KD; Hietaharju A; Jain P; Kopf A; Meyer AC; Raja SN; Rice ASC; Smith BH; Treede RD; Wiffen PJ
    Pain; 2015 May; 156(5):793-797. PubMed ID: 25894010
    [No Abstract]   [Full Text] [Related]  

  • 12. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2008; (950):backcover, vii-174. PubMed ID: 18754303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interpretation of China national essential medicines list 2018.
    Zuo W; Mei D; Sun W; Tang X; Niu Z; Gao D; Zhang B
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):191-200. PubMed ID: 31914825
    [No Abstract]   [Full Text] [Related]  

  • 14. What does it mean to put new hepatitis C drugs on a list of essential medicines?
    Urrutia J; Porteny T; Daniels N
    BMJ; 2016 Apr; 353():i2035. PubMed ID: 27106956
    [No Abstract]   [Full Text] [Related]  

  • 15. Availability, cost and affordability of essential cardiovascular disease medicines in the south west region of Cameroon: Preliminary findings from the Cameroon science for disease study.
    Dzudie A; Njume E; Abanda M; Aminde L; Hamadou B; Dzekem B; Azabji M; Doualla MS; Ngowe M; Kengne AP
    PLoS One; 2020; 15(3):e0229307. PubMed ID: 32130252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Selection and Use of Essential Medicines.
    World Health Organ Tech Rep Ser; 2015; (994):vii-xv, 1-546. PubMed ID: 27183787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selection and use of essential medicines.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (985):i-xiv, 1-219, back cover. PubMed ID: 25080778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding medicines for neurologic disorders on the WHO Model List.
    Rimmer K; Shah H; Thakur K
    Neurology; 2017 Mar; 88(10):e87-e91. PubMed ID: 28265046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the selection and use of essential medicines decrease inappropriate drug use?
    Reidenberg MM
    Clin Pharmacol Ther; 2009 Jun; 85(6):581-3. PubMed ID: 19451911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved neuropathic pain treatment in developing countries--a critical review of WHO essential list.
    Soyannwo OA
    Pain; 2015 May; 156(5):763-764. PubMed ID: 25719619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.